We recently published a list of Jim Cramer Discusses These 10 Stocks & Says Trump Should Carry A Howitzer And Be Soft. In ...

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

US President Donald Trump watched translated excerpts of an interview given by captivity survivor Eli Sharabi to the "Uvda" program, and invited him and other captivity survivors to the White ...

Tony Doris, the editorial page editor at The Palm Beach Post, was fired after he selected a cartoon that drew criticism from a nearby Jewish organization. Tony Doris was the editorial page editor ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks Jim Cramer recently discussed. In a recent appearance on CNBC’s Squawk on ...

David Ricks, Eli Lilly’s chief executive officer, told CNN that the company – whose revenue grew 32% to $45 billion last year on the back of its diabetes and weight loss drugs – wanted to ...

MONTREAL, Feb. 27, 2025 (GLOBE NEWSWIRE) — Ideal Protein, a leader in scientifically validated weight management solutions, today announced the release of its groundbreaking whitepaper ...

Eli Lilly plans to invest $27 billion in four new pharmaceutical manufacturing facilities in the U.S., expanding its domestic production of medications across multiple therapeutic areas.